In accordance with the clinical findings, the S1P concentration and the expression of SPHK1 and S1PR2 in our animal models of AP were elevated, indicating that the activation of S1P signaling may provide a risk factor for the onset of AP [25,26,98]. Here, S1PR2 is linked to alkaline phosphatase measurement.